查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2090918

全球幹細胞增殖技術市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Stem Cell Expansion Technologies Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 205 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球幹細胞增殖技術市場預計將從2025年的27.2億美元成長至2034年的69.7億美元，2026年至2034年的複合年成長率（CAGR）為11.02%。隨著再生醫學、細胞療法和生物醫學研究在全球範圍內的持續發展，該市場正經歷顯著成長。幹細胞增殖技術使研究人員和醫療保健專業人員能夠生產更多高品質的幹細胞，用於治療應用、藥物研發和臨床研究。對生物技術、再生醫學和精準醫學的投資增加，正在推動對先進增殖技術日益成長的需求。

生物反應器、細胞培養基、自動化生產平台和3D培養系統的技術進步正在提高細胞品質、可擴展性和生產效率。製藥公司、研究機構和生物技術公司正在擴大幹細胞研究，以開發治療慢性疾病、神經系統疾病、整形外科疾病和癌症的創新療法。臨床試驗的增加進一步推動了市場發展。

隨著個人化和再生醫學在現代醫療保健中日益重要，預計該市場將保持強勁成長動能。自動化細胞製造、人工智慧 (AI) 驅動的實驗室系統以及可擴展生產技術的持續創新將提升其商業性可行性。研究經費的增加、監管支持的加強以及對先進細胞療法日益成長的需求將繼續推動市場長期成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球幹細胞增殖技術市場：依技術分類

  • 市場分析、洞察與預測
  • 貼壁細胞增殖技術
  • 懸浮細胞培養增生技術
  • 自動化和封閉式系統育種技術
  • 其他

第5章 全球幹細胞增殖技術市場：依產品分類

  • 市場分析、洞察與預測
  • 消耗品
  • 生物反應器和增殖系統
  • 培養基和試劑
  • 其他

第6章 全球幹細胞增殖技術市場：依細胞類型分類

  • 市場分析、洞察與預測
  • 間質幹細胞（MSCs）
  • 造血幹細胞（HSCs）
  • 誘導性多功能幹細胞（iPS細胞）
  • 其他

第7章 全球幹細胞增殖技術市場：依應用分類

  • 市場分析、洞察與預測
  • 再生醫學
  • 細胞和基因治療
  • 藥物發現與開發
  • 其他

第8章 全球幹細胞增殖技術市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 生物技術和製藥公司
  • 學術研究機構
  • 受託研究機構（CRO）
  • 其他

第9章 全球幹細胞增殖技術市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Corning Incorporated
    • Danaher Corporation
    • Lonza Group AG
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • Sartorius AG
    • STEMCELL Technologies Inc
    • Takara Bio Inc
    • Terumo Blood And Cell Technologies
    • Thermo Fisher Scientific Inc
簡介目錄
Product Code: VMR112118963

The global stem cell expansion technologies market size is expected to reach USD 6.97 Billion in 2034 from USD 2.72 Billion in 2025, growing at a CAGR of 11.02 during 2026-2034.This market is witnessing significant growth as regenerative medicine, cell therapy, and biomedical research continue advancing worldwide. Stem cell expansion technologies enable researchers and healthcare providers to produce larger quantities of high-quality stem cells for therapeutic applications, drug discovery, and clinical research. Increasing investments in biotechnology, regenerative medicine, and precision healthcare are supporting growing demand for advanced expansion technologies.

Technological advancements in bioreactors, cell culture media, automated manufacturing platforms, and three-dimensional culture systems are improving cell quality, scalability, and production efficiency. Pharmaceutical companies, research institutions, and biotechnology firms are expanding stem cell research to develop innovative treatments for chronic diseases, neurological disorders, orthopedic conditions, and cancer. Growing clinical trials are further supporting market development.

The market is expected to maintain strong momentum as personalized medicine and regenerative therapies become increasingly important within modern healthcare. Continuous innovation in automated cell manufacturing, artificial intelligence-assisted laboratory systems, and scalable production technologies will improve commercial viability. Expanding research funding, increasing regulatory support, and rising demand for advanced cell therapies will continue driving long-term market growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

  • Adherent Cell Expansion Technologies
  • Suspension Cell Expansion Technologies
  • Automated & Closed-System Expansion Technologies
  • Others

By Product

  • Consumables
  • Bioreactors & Expansion Systems
  • Culture Media & Reagents
  • Others

By Cell Type

  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Others

By Application

  • Regenerative Medicine
  • Cell & Gene Therapy
  • Drug Discovery & Development
  • Others

By End User

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Others

COMPANIES PROFILED

  • Corning Incorporated, Danaher Corporation, Lonza Group AG, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., Terumo Blood and Cell Technologies, Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Adherent Cell Expansion Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Suspension Cell Expansion Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Automated & Closed-System Expansion Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Bioreactors & Expansion Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Culture Media & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY CELL TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Cell Type
  • 6.2. Mesenchymal Stem Cells (MSCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Hematopoietic Stem Cells (HSCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Induced Pluripotent Stem Cells (iPSCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cell & Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL STEM CELL EXPANSION TECHNOLOGIES MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Technology
    • 9.2.2 By Product
    • 9.2.3 By Cell Type
    • 9.2.4 By Application
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Technology
    • 9.3.2 By Product
    • 9.3.3 By Cell Type
    • 9.3.4 By Application
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Technology
    • 9.4.2 By Product
    • 9.4.3 By Cell Type
    • 9.4.4 By Application
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Technology
    • 9.5.2 By Product
    • 9.5.3 By Cell Type
    • 9.5.4 By Application
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Technology
    • 9.6.2 By Product
    • 9.6.3 By Cell Type
    • 9.6.4 By Application
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL STEM CELL EXPANSION TECHNOLOGIES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Corning Incorporated
    • 11.2.2 Danaher Corporation
    • 11.2.3 Lonza Group AG
    • 11.2.4 Merck KGaA
    • 11.2.5 Miltenyi Biotec B.V. & Co. KG
    • 11.2.6 Sartorius AG
    • 11.2.7 STEMCELL Technologies Inc
    • 11.2.8 Takara Bio Inc
    • 11.2.9 Terumo Blood And Cell Technologies
    • 11.2.10 Thermo Fisher Scientific Inc